Cell therapy for autoimmune diseases

Autoimmune diseases occur as a result of disorders in the immune system, leading to the development of a polyclonal immune response to its own antigens.

For effective correction of immune imbalance, mesenchymal stem cells (MSC) are used, which are a source of immunoregulatory substances aimed at increasing the pool of regulatory T-lymphocytes and suppression of effector T-cells.

The Institute has developed and implemented a method for the treatment of systemic lupus erythematosus (SLE) using a unique biomedical cell product (BMCP) based on allogeneic pooled MSCs of the olfactory lining.

The use of this BMKP is safe and allows you to effectively:

• suppress the formation of antibodies to their own tissues and normalize the patient’s immune status;
• slow down the processes of damage to internal organs and help restore their functional activity;
• normalize the indicators of coagulogram and lipid profile, transaminases, and hepatic markers;
• reduce the dose of basic therapy drugs;
• increase the duration of remission and reduce the frequency of relapses;

Ultimately, the use of this BMCP improves the quality of life of patients and prevents disability.

You can get the additional information and make an appointment with specialists at the following phone numbers:
+375 (17) 378 18 21
+375 (44) 574 18 21 (Viber, WhatsApp, Telegram)
e-mail: med@ibce.by